Sponsors (14)
The bill caps annual out‑of‑pocket prescription drug spending—providing substantial financial protection and predictability for patients and workers—but shifts costs onto insurers, employers, and potentially taxpayers, which may lead to higher premiums, narrower drug coverage, or other cost offsets.
People with chronic conditions will pay less for prescription drugs because annual out-of-pocket costs are capped at $2,000 per individual / $4,000 per family beginning in 2026.
Families who buy prescription drugs will have more predictable annual drug spending because the cap applies per year and will be indexed to medical CPI after 2026.
Employees covered by employer-sponsored plans will receive the same drug cost protections as Marketplace enrollees because the cap is extended to group health plans and relevant federal rules (PHS Act, ERISA, tax code).
Insurers and employers are likely to face higher costs to cover drugs, which could translate into higher premiums or larger employer contributions for health plans.
Plan sponsors may narrow drug formularies or increase non-drug cost-sharing (e.g., higher deductibles or copays for other services) to offset the cap, potentially limiting access to some medications or raising other out-of-pocket costs.
Federal taxpayers could incur higher costs if increased plan expenses raise the level of federal subsidies for Marketplace plans or affect tax benefits tied to employer coverage.
Based on analysis of 2 sections of legislative text.
Sets a national annual cap on how much people must pay out of pocket for prescription drugs in most private and Marketplace health plans: $2,000 per person and $4,000 per family for plan years starting in 2026, with yearly inflation adjustments tied to the medical CPI‑U. The cap is added across the Affordable Care Act marketplace rules, group health plan law (ERISA), the Public Health Service Act, and the Internal Revenue Code so it applies to qualified health plans and employer-sponsored group coverage.
Introduced February 11, 2025 by Raphael Gamaliel Warnock · Last progress February 11, 2025